Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

NCT04446286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-10-08

No results posted yet for this study

Summary

Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres

Conditions

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2020-08-18
Completion
2020-08-18

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446286 on ClinicalTrials.gov